Cumberland Pharmaceuticals Inc [NASDAQ: CPIX] traded at a high on Tuesday, posting a 14.59 gain after which it closed the day’ session at $2.67.
The results of the trading session contributed to over 7435236 shares changing hands. Over the past one week, the price volatility of Cumberland Pharmaceuticals Inc stands at 20.57% while the volatility over the past one month is 13.48%.
The market cap for CPIX stock reached $37.49 million, with 14.01 million shares outstanding and 7.84 million shares in the current float. Compared to the average trading volume of 1.85M shares, CPIX reached a trading volume of 7435236 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Cumberland Pharmaceuticals Inc [CPIX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CPIX shares is $9.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CPIX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
UBS have made an estimate for Cumberland Pharmaceuticals Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 12, 2012. While these analysts kept the previous recommendation, UBS dropped their target price from $8 to $6.50. The new note on the price target was released on February 01, 2011, representing the official price target for Cumberland Pharmaceuticals Inc stock. Previously, the target price had yet another drop from $10 to $8, while UBS kept a Neutral rating on CPIX stock. On August 17, 2010, analysts decreased their price target for CPIX shares from 11 to 10.
The Average True Range (ATR) for Cumberland Pharmaceuticals Inc is set at 0.32, with the Price to Sales ratio for CPIX stock in the period of the last 12 months amounting to 1.02. The Price to Book ratio for the last quarter was 1.51, with the Price to Cash per share for the same quarter was set at 1.24.
How has CPIX stock performed recently?
Cumberland Pharmaceuticals Inc [CPIX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.59. With this latest performance, CPIX shares gained by 10.33% in over the last four-week period, additionally plugging by 82.88% over the last 6 months – not to mention a rise of 25.94% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CPIX stock in for the last two-week period is set at 67.72, with the RSI for the last a single of trading hit 70.21, and the three-weeks RSI is set at 66.62 for Cumberland Pharmaceuticals Inc [CPIX]. The present Moving Average for the last 50 days of trading for this stock 1.71, while it was recorded at 2.39 for the last single week of trading, and 1.51 for the last 200 days.
Cumberland Pharmaceuticals Inc [CPIX]: Deeper insight into the fundamentals
Cumberland Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.99 and a Current Ratio set at 1.13.
Insider trade positions for Cumberland Pharmaceuticals Inc [CPIX]
There are presently around $14.69%, or 26.28%% of CPIX stock, in the hands of institutional investors. The top three institutional holders of CPIX stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 0.54 million shares, which is approximately 3.8173%. VANGUARD GROUP INC, holding 0.37 million shares of the stock with an approximate value of $$0.57 million in CPIX stocks shares; and VANGUARD GROUP INC, currently with $$0.47 million in CPIX stock with ownership which is approximately 2.1571%.
